NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
June 3, 2025 — SunKnowledge Inc. revolutionizes Prior Authorization with AI-driven solutions, ensuring efficiency and compliance in healthcare administration. Discover how they're shaping the future.
June 3, 2025 — Lorati's NanoClay Paste introduces a natural, mineral-based solution for chronic wounds and skin infections, offering fast, safe healing without antibiotics.
June 3, 2025 — Purpose Healing Center in Phoenix expands addiction and mental health services for the homeless during extreme summer heat, offering comprehensive care and transportation.
June 3, 2025 — Dying Inside Nonprofit launches new website and expands services for survivors of human trafficking and foster care youth, raising over $7,000 in May.
June 3, 2025 — Dr. Lama Tolaymat recognized as 2025 Castle Connolly Top Doctor for her excellence in Maternal-Fetal Medicine and commitment to compassionate care.
June 2, 2025 — Stradley Ronon strengthens its litigation team with Jordann Conaboy and Benjamin McCoy, enhancing its capabilities in health care and managed care disputes.
June 2, 2025 — South Korean team develops AI model to predict cancer patients' responses to immunotherapy, potentially revolutionizing cancer treatment with more accurate and personalized therapies.
June 2, 2025 — Telomir Pharmaceuticals participates in BIO International Convention 2025, plans for IND application of Telomir-1, a potential anti-aging treatment with broad therapeutic applications. Stay updated on Telomir's advancements in longevity science and innovative pharmaceuticals.
June 2, 2025 — Nutriband Inc. reports impressive Q1 revenue growth and partnerships, including the development of AVERSA Fentanyl patch. Learn more about the company's strategic initiatives and potential market impact.
June 2, 2025 — Litchfield Hills Research initiates coverage of Inspira Technologies with a Buy rating and $2 price target, showcasing the company's innovative ART500 system and potential for disrupting the mechanical ventilators market. Learn more about Inspira's FDA-cleared technology and global commercial rollout discussions.
June 2, 2025 — Discover how Patty Hayward at Talkdesk is using AI to transform healthcare contact centers, driving value-based care and improving patient outcomes.
May 31, 2025 — Discover the groundbreaking research uncovering the dynamic architecture of the pyruvate dehydrogenase complex (PDHc) and its implications for metabolic disease research. Learn how this study could revolutionize therapeutic strategies for PDHc-related disorders and pave the way for advances in structural biology and drug development.
May 31, 2025 — Researchers unveil RADICAL, a cutting-edge chemogenetic tool for precise neuronal control using cyclohexanol. This breakthrough in neuroscience offers new possibilities for research and therapy in neurological disorders.
May 30, 2025 — Adageis introduces AI-powered solutions for healthcare providers transitioning to value-based care, including the ProActive Care Platform with predictive analytics. Learn how Adageis is revolutionizing healthcare delivery and improving patient outcomes.
May 30, 2025 — American Heart Association warns of cardiovascular risks from Canadian wildfire smoke drifting into the U.S., offering prevention tips and resources.
May 30, 2025 — American Beverage Association sues Santa Cruz over sugary drink tax, challenging public health measures aimed at reducing diabetes and heart disease risks.
May 30, 2025 — New study reveals link between autism spectrum disorder and Parkinson's disease, highlighting shared biological mechanisms. Clene Inc. (NASDAQ: CLNN) could benefit from this research. Learn more about the study findings and implications here.
May 30, 2025 — Scinai Immunotherapeutics (SCNI) reports Q1 2025 financial results with revenue growth and decreased net loss. Learn more about the biopharmaceutical company's performance and innovative pipeline.
May 30, 2025 — Lantern Pharma reports strong preclinical data for LP-184 in treating pediatric brain cancer, showing promising results for ATRT therapy. The findings could lead to significant advancements in the treatment of this rare and aggressive cancer.
May 30, 2025 — Quantum BioPharma (QNTM) settles disputes with former CEO, Dr. Raza Bokhari, injecting $2.35M into the business. The agreement provides financial stability and focuses on drug development for neurodegenerative disorders like multiple sclerosis.